Silingardi V, Montemurno C, Venezia L, Franceschi C, Riva P C, Emilia G, Masi M, Merelli E, Torelli G, Licastro F, Fantini M P, Federico M
Minerva Med. 1979 Nov 3;70(48):3269-84.
6 cases of Behçet's disease are reported. Diagnosis was particularly arduous because the typical triad of symptoms (oral aphthae, genital ulcers, uveitis) was masked by secondary disturbances in other organs and systems. Immunology confirmed the presence in these patients of changes in various in vivo and in vitro tests and particularly interesting was the aspecific cutaneous hypersensitivity seen in 5 cases and enhanced lymphocyte blastic transformation. This was seen spontaneously and following PHA. On the basis of the outcome of the studies carried out and the literature data, the possibility that Behçet's disease may contain immunological changes and changes in the mechanisms that regulate quinine, complement and clotting activation is suggested. Therapeutically, confirmation was obtained of the effectiveness, at least temporarily, of corticosteroid treatment and antilymphocyte globulin was experimented for the first time in these patients. This might be used to replace the immune depressant antiblastic substances already successfully employed in patients with Behçet's disease.
报告了6例白塞病病例。诊断特别困难,因为典型的三联征症状(口腔溃疡、生殖器溃疡、葡萄膜炎)被其他器官和系统的继发性紊乱所掩盖。免疫学证实这些患者在各种体内和体外试验中存在变化,特别有趣的是5例患者出现的非特异性皮肤超敏反应以及淋巴细胞增殖转化增强。这在自发情况下以及在PHA刺激后均可观察到。根据所开展研究的结果和文献数据,提示白塞病可能存在免疫变化以及调节奎宁(此处quinine疑似有误,可能是补体等相关内容)、补体和凝血激活的机制变化。在治疗方面,证实了皮质类固醇治疗至少在短期内是有效的,并且首次在这些患者中试验了抗淋巴细胞球蛋白。这可能用于替代已成功应用于白塞病患者的免疫抑制抗增殖物质。